Results 151 to 160 of about 51,637 (256)

Myasthenia gravis and anesthesia [PDF]

, 2017
Stanislav Voháňka, Magda Horáková
openalex   +1 more source

Obesity as a Risk Factor for Autoimmune Diseases: A Systematic Review and Meta‐Analysis

Obesity, Volume 34, Issue 1, Page 36-50, January 2026.
Summary of the meta‐analysis including 26 studies (8 cross‐sectional, 18 longitudinal) investigating the association between obesity and autoimmune diseases. Findings show increased prevalence and incidence of rheumatoid arthritis, psoriasis, multiple sclerosis, and inflammatory bowel diseases in people with obesity, suggesting that obesity may ...
Ilaria Spatocco, Giorgia Mele, Giusy De Rosa, Clorinda Fusco, Kristyna Ruggiero, Valeria Pellegrini, Francesca Carreras, Rosalba La Grotta, Antonio Ceriello, Claudio Procaccini, Giuseppe Matarese, Francesco Prattichizzo, Paola de Candia   +12 more
wiley   +1 more source

Myasthenia Gravis in a Child With Schimke Immuno-Osseous Dysplasia: A Case Report. [PDF]

Clin Case Rep
Al Riyami MS, Al Alawi I, Al Riyami M, Al Gaithi B, Al Saidi S, Al Shuaili I, Al Kalbani N, Al Maki N.   +7 more
europepmc   +1 more source

Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein

, 1997

openalex   +1 more source

Additional file 3 of Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses

, 2021
Shuang Li, Xu Wang, Tianfeng Wang, Huixue Zhang, Xiaoyu Lu, Li Liu, Lifang Li, Chunrui Bo, Xiaotong Kong, Si Xu, Shangwei Ning, Jianjian Wang, Lihua Wang   +12 more
openalex   +1 more source

Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation

Small Science, Volume 6, Issue 1, January 2026.
Tregs control immune tolerance but can also enable tumor escape. Nanomaterials can now expand or stabilize Tregs to treat autoimmunity and support transplantation or conversely disrupt tumor Tregs to boost antitumor immunity. We also discuss unintended Treg modulation by nanoparticles, safety and manufacturing challenges, and future translational ...
Yiyin Chen, Haibo Huang, Xiang Wang, Xinghao Yu, Ziyan Huang, Zhou Jin, Chen Chen, Yan Chen, Bruce R. Blazar, Yang Xu, Yunjie Lu   +10 more
wiley   +1 more source

Neoadjuvant Glucocorticoids Facilitate Resection in Advanced B‐Type Thymomas: A Propensity‐Matched Analysis of Surgical and Survival Outcomes

Thoracic Cancer, Volume 17, Issue 1, January 2026.
Neoadjuvant glucocorticoids facilitated less invasive and more complete resection of advanced B‐type thymomas, leading to reduced operative morbidity and improved progression‐free survival compared to upfront surgery. This study supports a novel downstaging strategy for this challenging disease.
Zhen Yu, Xintao Yu, Jian Cui, Xiang Gao, Xingguo Yang, Ji Ke, Baoxun Zhang, Lei Yu   +7 more
wiley   +1 more source

Third distant recurrence of benign thymoma in a patient with myasthenia gravis

, 2019
Justin T. Van Backer, Alex Cedeno-Rodriguez, John P. Nabagiez   +2 more
openalex   +2 more sources

Rare association of thymoma, myasthenia gravis and sarcoidosis : a case report [PDF]

, 2008
Mohankumar Kurukumbi, Roger Weir, Janaki Kalyanam, Mansoor Nasim, Annapurni Jayam‐Trouth   +4 more
openalex   +1 more source

Immune‐Mediated Multilineage Cytopenias in Thymoma: A Retrospective Case Series

Thoracic Cancer, Volume 17, Issue 2, January 2026.
Thymoma‐associated immune dysregulation can drive multilineage cytopenias through T‐cell–mediated mechanisms. Patients show heterogeneous marrow involvement, frequent relapse, and variable lineage‐specific responses to immunosuppressive therapy, with sirolimus demonstrating activity in T‐cell‐driven phenotypes. ABSTRACT Background Thymoma is associated
Naibo Hu, Yansong Wei, Weinan Lin, Xifeng Dong, Huaquan Wang   +4 more
wiley   +1 more source